References
- GoASMozaffarianDRogerVLAmerican Heart Association Statistics Committee and Stroke Statistics SubcommitteeHeart disease and stroke statistics – 2014 update: a report from the American Heart AssociationCirculation20141293e28e29224352519
- GüderGBrennerSStörkSHoesARuttenFHChronic obstructive pulmonary disease in heart failure: accurate diagnosis and treatmentEur J Heart Fail201416121273128225345927
- LiaoKMLiangFWLiCYRisks of all-cause and site-specific fractures among hospitalized patients with COPDMedicine (Baltimore)20169540e507027749576
- LiaoKMLuHYComplications after total knee replacement in patients with chronic obstructive pulmonary disease: a nationwide case-control studyMedicine (Baltimore)20169537e483527631237
- ChenCYLiaoKMChronic obstructive pulmonary disease is associated with risk of chronic kidney disease: a nationwide case-cohort studySci Rep201662585527166152
- LiaoKMLuHYA National analysis of complications following total hip replacement in patients with chronic obstructive pulmonary diseaseMedicine (Baltimore)20169512e318227015210
- HoCHChenYCChuCCWangJJLiaoKMPostoperative complications after coronary artery bypass grafting in patients with chronic obstructive pulmonary diseaseMedicine (Baltimore)2016958e292626937939
- ChenCYLiaoKMThe incidence of deep vein thrombosis in Asian patients with chronic obstructive pulmonary diseaseMedicine (Baltimore)20159444e174126554770
- LiaoKMHoCHKoSCLiCYIncreased risk of dementia in patients with chronic obstructive pulmonary diseaseMedicine (Baltimore)20159423e93026061317
- HawkinsNMPetrieMCMacdonaldMRHeart failure and chronic obstructive pulmonary disease the quandary of beta-blockers and beta-agonistsJ Am Coll Cardiol201157212127213821596228
- LainscakMPodbregarMKovacicDRozmanJvon HaehlingSDifferences between bisoprolol and carvedilol in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized trialRespir Med2011105suppl 1S44S4922015086
- SuVYChangYSHuYWCarvedilol, bisoprolol, and metoprolol use in patients with coexistent heart failure and chronic obstructive pulmonary diseaseMedicine (Baltimore)2016955e242726844454
- TangCHWangCCChenTHHongCYSueYMPrognostic benefits of carvedilol, bisoprolol, and metoprolol controlled release/extended release in hemodialysis patients with heart failure: a 10-year cohortJ Am Heart Assoc201651e00258426738790
- TangCHChenTHWangCCHongCYHuangKCSueYMRenin-angiotensin system blockade in heart failure patients on long-term haemodialysis in TaiwanEur J Heart Fail201315101194120223671265
- LiCHChenWCLiaoWCThe association between chronic obstructive pulmonary disease and Parkinson’s disease: a nationwide population-based retrospective cohort studyQJM20151081394525024356
- TsaiMJChenCYHuangYBLong-acting inhaled bronchodilator and risk of vascular events in patients with chronic obstructive pulmonary disease in Taiwan populationMedicine (Baltimore)2016958e78fe
- ChungWSLaiCYLinCLKaoCHAdverse respiratory events associated with hypnotics use in patients of chronic obstructive pulmonary disease: a population-based case-control studyMedicine (Baltimore)20159427e111026166105
- GottliebSSMcCarterRJVogelRAEffect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarctionN Engl J Med199833984894979709041
- ChenJRadfordMJWangYMarciniakTAKrumholzHMEffectiveness of beta-blocker therapy after acute myocardial infarction in elderly patients with chronic obstructive pulmonary disease or asthmaJ Am Coll Cardiol20013771950195611401137
- SinDDMcAlisterFAThe effects of beta-blockers on morbidity and mortality in a population-based cohort of 11,942 elderly patients with heart failureAm J Med2002113865065612505115
- AuDHBrysonCLFanVSBeta-blockers as single-agent therapy for hypertension and the risk of mortality among patients with chronic obstructive pulmonary diseaseAm J Med20041171292593115629731
- StaszewskyLWongMMassonSValsartan Heart Failure Trial InvestigatorsClinical, neurohormonal, and inflammatory markers and overall prognostic role of chronic obstructive pulmonary disease in patients with heart failure: data from the Val-HeFT heart failure trialJ Card Fail2007131079780418068611
- MalerbaMMontuschiPRadaeliAPirisiMRole of beta-blockers in patients with COPD: current perspectiveDrug Discov Today201520112913525238736
- DransfieldMTRoweSMJohnsonJEBaileyWCGeraldLBUse of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPDThorax200863430130517951276
- van GestelYRHoeksSESinDDImpact of cardioselective beta-blockers on mortality in patients with chronic obstructive pulmonary disease and atherosclerosisAm J Respir Crit Care Med2008178769570018565952
- HawkinsNMHuangZPieperKSValsartan in Acute Myocardial Infarction Trial InvestigatorsChronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the valsartan in acute myocardial infarction trial (VALIANT)Eur J Heart Fail200911329229819176539
- RuttenFHZuithoffNPHakEGrobbeeDEHoesAWBeta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary diseaseArch Intern Med20101701088088720498416
- ShortPMLipworthSIElderDHSchembriSLipworthBJEffect of beta blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort studyBMJ2011342d254921558357
- MentzRJWojdylaDFiuzatMChiswellKFonarowGCO’ConnorCMAssociation of beta-blocker use and selectivity with outcomes in patients with heart failure and chronic obstructive pulmonary disease (from OPTIMIZE-HF)Am J Cardiol2013111458258723200803
- Guideline for the Management of Chronic Obstructive Pulmonary DiseaseTaiwan Society of Pulmonary and Critical Care Medicine2007 Available from: http://tmuh.tmu.edu.tw/tmuh_web/Chest/pdf/Chest_teaching_k.pdfAccessed June 23, 2016
- Guideline for the Management of Chronic Obstructive Pulmonary DiseaseTaiwan Society of Pulmonary and Critical Care Medicine2017 Available from: http://www.rtsroc.org.tw/branch/archive/news/item/2/2017%E5%B9%B4%E5%8F%B0%E7%81%A3COPD%20%E8%A8%BA%E7%99%82%E6%8C%87%E5%BC%95-1.pdfAccessed June 23, 2017
- HungCTLiSFLeeMHTrends and burden of bronchiectasis-associated hospitalizations in Taiwan, 1998–2008J Med Health2013224352
- SeitzAEOlivierKNSteinerCAMontes de OcaRHollandSMPrevotsDRTrends and burden of bronchiectasis-associated hospitalizations in the United States, 1993–2006Chest2010138494499920435655
- SalpeterSOrmistonTSalpeterECardioselective beta-blockers for chronic obstructive pulmonary diseaseCochrane Database Syst Rev20054CD003566
- JabbourAMacdonaldPSKeoghAMDifferences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trialJ Am Coll Cardiol201055171780178720413026
- DuQSunYDingNLuLChenYBeta-blockers reduced the risk of mortality and exacerbation in patients with COPD: a meta-analysis of observational studiesPLoS One2014911e11304825427000
- KoshucharovaGKleinWLercherPDifferent beta-blocking effects of carvedilol and bisoprolol in humansJ Clin Basic Cardiol2001415356
- MarciniakTAEllerbeckEFRadfordMJImproving the quality of care for medicare patients with acute myocardial infarction: results from the cooperative cardiovascular projectJAMA199827917135113579582042
- Heart Failure Society of AmericaLindenfeldJAlbertNMHFSA 2010 comprehensive heart failure practice guidelineJ Card Fail2010166e1e19420610207